Abstract
Kimotab is a proteolytic medicine which consists of Bromelain and Trypsin. It was given through mouth to 24 chronic paranasal sinusitis patients.
They consciously responded to it in 5 to 14 days. The intranasal appearance became better in 10 to 14 days. Roentgenologically the effects appeared in 10 to 20 days.
Eleven of the patients (50%) remarkably responded, nine (37.5%) medially, and the rest three(12.5%) were unresponsive. So, the patients who were responsive amounted to 87.5%.
This percentage is very high probably because Kimotab is a mixture medicine and the author selected the patients who had been suffering for a shorter period (one year on an average) and whose intranasal appearance was mild.
